marginally significantP = 0.049
LUSC cell lines with amplification of EGFR show marginally significant sensitivity to lapatinib compared with those of LUSC cell lines with wild‐type EGFR in the CCLE database ( P = 0.049, Wilcoxon rank‐sum test, Fig. 7 D).